LIVN vs. STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, and PRCT
Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
LivaNova vs.
LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.
Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.
97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
LivaNova has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.
LivaNova received 378 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.80% of users gave LivaNova an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.
Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, LivaNova had 10 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for LivaNova and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.44 beat LivaNova's score of 1.33 indicating that Stevanato Group is being referred to more favorably in the news media.
LivaNova currently has a consensus target price of $59.29, indicating a potential upside of 35.79%. Given LivaNova's stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than Stevanato Group.
Summary
LivaNova beats Stevanato Group on 12 of the 18 factors compared between the two stocks.
Get LivaNova News Delivered to You Automatically
Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LivaNova Competitors List
Related Companies and Tools
This page (NASDAQ:LIVN) was last updated on 5/22/2025 by MarketBeat.com Staff